Stock & Company Details
Aprea Therapeutics Inc $APRE
Price:
N/A
N/A
13M
$9.4M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.49
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
APRE technical indicators
Latest Aprea Therapeutics Inc (APRE) indicator readings as of 2026-09-18.
APRE's 14-day RSI is 49.5, in neutral territory. At $0.76 it is trading 5.1% below its 200-day moving average of $0.80, and above its 50-day average of $0.72. Price sits in the middle of its Bollinger Bands ($0.66 to $0.95). ADX reads 37.5, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Finance Bot
Ask your questions
Start by typing a question below.
